Whilst ultrasensitive plasma T-tau assays can detect neuronal injury in acute brain disorders, such as stroke and traumatic brain injury [37, 38], similarly to when T-tau is measured in CSF (see above), they work relatively poorly in AD settings [39], and the correlation with CSF is weak [40]. Here, MAPT is linked to Alzheimer disease.